Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar-Apr;37(2):362-366.
doi: 10.12669/pjms.37.2.2670.

Clinical outcome of Montelukast Sodium in Children with Adenoid Hypertrophy

Syed Ali Naqi  1 , Ahmad Hassan Ashfaq  2 , Mumtaz Ahmad Umar  3 , Jais Kumar Karmani  4 , Naveed Arshad  5
Affiliations

Clinical outcome of Montelukast Sodium in Children with Adenoid Hypertrophy

Syed Ali Naqi et al. Pak J Med Sci. 2021 Mar-Apr.

Abstract

Background & objectives: Generally, the blockage of upper respiratory tract in children is seen with the hypertrophy of adenoids and tonsils. Normally for patients with adenoid hypertrophy (AH), Adenoidectomy with or without Tonsillectomy is carried out, however it has its own complications like haemorrhage and recurrence of adenoid tissue. Consequently, therapeutic approach has increased extraordinary consideration rather than surgical procedure. The inflammatory process proposed for AH has prompted the utilization of anti-inflammatory drugs to treat this issue. The objective of this study was to assess the impacts of Montelukast sodium in children with enlarged adenoids.

Methods: A randomized controlled trail was performed from April 2018 to March 2019 in the Otorhinolaryngology clinic of Dr. Akbar Niazi Teaching Hospital, Islamabad. In this randomized, placebo treatment-controlled trial, 60 children aged 4-12 years meeting inclusion criteria were isolated into two groups. The study group was treated with Montelukast sodium 5mg consistently for three months while the control group got placebo treatment for a similar timeframe. A questionnaire was filled by parents/ guardians of every child before and after the intervention to evaluate the severity of sleep discomfort, snoring and mouth breathing.

Results: Following 3 months of treatment, significant reduction in size of the adenoids was seen in 76% of study group compared with just 3% of control group getting placebo treatment.

Conclusion: Montelukast sodium seems to be effective in the reduction of the size of adenoids and improvement in clinical manifestations. It can be viewed as a viable option in contrast to surgical treatment in children with hypertrophy of adenoids.

Keywords: Adenoid; Hypertrophy; Montelukast sodium; Obstructive sleep apnea syndrome.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Snoring scores before and after treatment.
Fig.2
Fig.2
Before and after treatment of sleep discomfort score.
Fig.3
Fig.3
Before and after treatment of mouth breathing score.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Liming BJ, Ryan M, Mack D, Ahmad I, Camacho M. Montelukast and Nasal Corticosteroids to Treat Pediatric Obstructive Sleep Apnea:A Systematic Review and Meta-analysis. Otolaryng Head Neck Surg. 2019;160(4):594–602. doi:10.1177/0194599818815683. - PubMed
    1. Yan Y, Song Y, Liu Y, Su J, Cui L, Wang J, et al. Early Stage Impacts of Adenoidectomy With/Without Tonsillectomy on Immune Functions of Children Aged Less Than Three Years. Pediat Aller Imm Pul. 2019;32(1):18–22. doi:10.1089/ped.2018.0964. - PMC - PubMed
    1. Sharifkashani S, Dabirmoghaddam P, Kheirkhah M, Hosseinzadehnik R. A new clinical scoring system for adenoid hypertrophy in children. Iran J Otolaryng. 2015;27(78):55. - PMC - PubMed
    1. Babakurban ST, Aydın E. Adenoidectomy:current approaches and review of the literature. Kulak Burun Bogaz Ihtis Derg. 2016;26(3):181–190. doi:10.5606/kbbihtisas.2016.32815. - PubMed
    1. Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for children with obstructive sleep apnea:results of a double-blind randomized, placebo-controlled trial. Ann ATS. 2016;13(10):1736–1741. doi:10.1513/AnnalsATS.201606-432OC. - PMC - PubMed

LinkOut - more resources